Better Health, Brighter Future
April 28, 2016 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that Olivier Bohuon, Non-Executive Director of the Company, has been appointed as a member of the Remuneration Committee with immediate effect.
Senior Assistant Company Secretary
|Sarah Elton-Farr||[email protected]||+44 1256 894157|
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.